• Services
    • Overview
    • Antibody Profiling Solutions
    • Oncology Drug Screening
    • Immunoprofiling
    • Vaccine Development
    • Custom Protein Arrays
  • Applications
        • Disease Area
          • Autoimmune Disease
          • Immuno-Oncology
          • Neurological Disease
          • Infectious Disease
        • Application Area
          • Biomarker Discovery
          • Patient Stratification
          • Disease and Treatment Outcome Prediction
          • Diagnostics & CDx Development
  • Technology
    • Overview
    • KREX Protein Folding Technology
    • Antibodies as Biomarkers
    • Bioinformatics for Antibody Profiling
  • Resources
    • Blog
    • Videos
    • Featured Publications
    • Product Information
    • White Paper & Case Studies
    • Protein List
    • FAQs
  • About
    • Company Overview
      • Patents
    • Meet Our Team
    • News & Events
  • Menu Menu
  • Join Our Team
  • Contact

News & Events

What’s New at Sengenics: News & Events

Press Releases

Sengenics Corporation Announces Yvonne Linney, PhD as New Board Director

January 9, 2023
Learn More →
Press Releases

Sengenics Broadens Its Systems Serology Tools to Enable the Detection of a Wider Range of Autoantibody Biomarkers

November 30, 2022
Learn More →
Events

British Society for Immunology Congress 2022. Visit us at booth #17.

December 5 – 8, 2022
ACC Liverpool, Liverpool, UK
Learn More →
Events

50th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology.

November 29 - December 2, 2022
Melbourne Convention & Exhibition Centre (MCEC), Melbourne, Australia
Learn More →
Press Releases

Sengenics Prepares for Next Phase Growth and Welcomes Bioscience Industry Leader as New CEO

September 7, 2022
Learn More →
Events

Sengenics will be exhibiting at the Neuroscience 2022. Visit us at booth #621.

November 12-16, 2022
San Diego Convention Center, San Diego, CA
Learn More →
Events

Sengenics will be exhibiting at the Frontiers in Cancer Science in Singapore. Get in touch to plan a meeting.

November 7 - 9, 2022
Nanyang Tech University, Singapore
Learn More →
Events

Sengenics will be exhibiting at the ELRIG Drug Discovery UK 2022. Get in touch to plan a meeting.

October 4 - 5, 2022
ExCeL, London, UK
Learn More →
Events

Sengenics will be exhibiting at the Biomarkers US 2022. Visit us at booth #8.

October 3 - 4, 2022
Doubletree by Hilton San Diego, CA
Learn More →
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ›
Loading...

  • Services
  • Applications
  • Technology
  • Resources
  • About

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

© 2024 Sengenics Corporation LLC. All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D

Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy | Sitemap

Design and development by RainCastle Communications.

"*" indicates required fields

Fill in the form to download the publication

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

"*" Indicates required fields

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation


Read the Review

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.